Disclosure Of Fair Value Measurement [Text Block]

Mithra Pharmaceuticals S.A. - Filing #3183078

Concept As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
442,414,000 EUR
421,918,000 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
33,687,000 EUR
396,254,000 EUR
41,228,000 EUR
19,934,000 EUR
408,647,000 EUR
33,840,000 EUR
336,633,000 EUR
2,545,000 EUR
340,769,000 EUR
32,250,000 EUR
157,737,000 EUR
219,759,000 EUR
31,271,000 EUR
332,535,000 EUR
13,690,000 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.